BlackLine Stock Turnaround After Potrero Stake: Worth It?
A notable hedge fund just put $20 million into BlackLine. Is this the spark a turnaround scenario needs, or a cautiou...
Zero based budgeting yields tangible outcomes compared to traditional budgeting, including tighter control and clearer allocation of resources.
22,247 articlesA notable hedge fund just put $20 million into BlackLine. Is this the spark a turnaround scenario needs, or a cautiou...
When a Materion director trims stake, investors should look beyond the sale. The bigger signal may lie in the company...
Dive into how to read myriad genetics (mygn) 2025 earnings transcripts, spot growth drivers, assess risk, and build a...
Mission Produce (AVO) 2026 Q2 results drive critical questions about margins, supply, and stock strategy. This deep d...
TG Therapeutics faces a pivotal year as it closes 2025 with a tighter focus on its flagship therapeutics portfolio an...
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Unpack the essentials of fulgent genetics (flgt) earnings in plain language. This guide translates the earnings trans...
A recent insider move at Precigen has many investors asking if a CFO’s share sale signals trouble. This deep-dive bre...
Kroger reports fiscal 2025 results with a GAAP payout surge caused by a major impairment, yet cash flow and 2026 earn...
A countywide fraud-prevention pilot is introducing a half-sheet questionnaire for withdrawals of $5,000 or more. Lear...
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
An executive stock sale can signal many things. This article breaks down the numbers, the reporting rules, and practi...